Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2018

01-12-2018 | ASO Author Reflections

ASO Author Reflections: Venous Thromboembolism After Esophagectomy—The Importance of an Optimal Strategy for Thromboprophylaxis

Authors: Naoya Yoshida, MD, PhD, Hideo Baba, MD, PhD

Published in: Annals of Surgical Oncology | Special Issue 3/2018

Login to get access

Excerpt

Esophagectomies are associated with more frequent postoperative venous thromboembolism (VTE) than other gastroenterological surgeries.1 This may be due to frequent smoking and alcohol consumption, which are risk factors for VTE and esophageal cancer. Moreover, the increased use of neoadjuvant therapy for locally advanced esophageal cancer can also affect frequent VTEs.2 Most previously reported incidences included only symptomatic VTE, therefore the true incidence rate while taking asymptomatic VTE into account was not known because of the lack of prospective observational studies. An optimal strategy for thromboprophylaxis after esophagectomy has not been well established. Several general guidelines for thromboprophylaxis in patients with cancer are commonly used; however, the incidence of postoperative VTE remains high. Moreover, previous studies suggested that 11% of patients who underwent esophagectomy experienced VTE after hospital discharge,3 and 14% of readmissions after esophagectomy were due to VTE.4 These results imply that the previous strategy is inadequate, and there is a population of patients requiring further thromboprophylaxis after esophagectomy. …
Literature
1.
go back to reference Bellini G, Teng A, Kotecha N, et al. The identification of risk factors for venous thromboembolism in gastrointestinal oncologic surgery. J Surg Res. 2016;205(2):279–85.CrossRefPubMed Bellini G, Teng A, Kotecha N, et al. The identification of risk factors for venous thromboembolism in gastrointestinal oncologic surgery. J Surg Res. 2016;205(2):279–85.CrossRefPubMed
2.
go back to reference Sabra MJ, Smotherman C, Kraemer DF, Nussbaum MS, Tepas JJ Rd, Awad ZT. The effects of neoadjuvant therapy on morbidity and mortality of esophagectomy for esophageal cancer: American college of surgeons national surgical quality improvement program (ACS-NSQIP) 2005–2012. J Surg Oncol. 2017;115(3):296–300. Sabra MJ, Smotherman C, Kraemer DF, Nussbaum MS, Tepas JJ Rd, Awad ZT. The effects of neoadjuvant therapy on morbidity and mortality of esophagectomy for esophageal cancer: American college of surgeons national surgical quality improvement program (ACS-NSQIP) 2005–2012. J Surg Oncol. 2017;115(3):296–300.
3.
go back to reference Byrne M, Reynolds JV, O’Donnell JS, et al. Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery. Br J Cancer. 2010;102(1):73–9.CrossRefPubMed Byrne M, Reynolds JV, O’Donnell JS, et al. Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery. Br J Cancer. 2010;102(1):73–9.CrossRefPubMed
4.
go back to reference Shah SP, Xu T, Hooker CM, et al. Why are patients being readmitted after surgery for esophageal cancer? J Thorac Cardiovasc Surg. 2015;149(5):1384–91.CrossRefPubMed Shah SP, Xu T, Hooker CM, et al. Why are patients being readmitted after surgery for esophageal cancer? J Thorac Cardiovasc Surg. 2015;149(5):1384–91.CrossRefPubMed
5.
go back to reference Yoshida N, Baba Y, Miyamoto Y, et al. Prophylaxis of postoperative venous thromboembolism using enoxaparin after esophagectomy: a prospective observational study of effectiveness and safety. Ann Surg Oncol. 2018;25:2434–40.CrossRefPubMed Yoshida N, Baba Y, Miyamoto Y, et al. Prophylaxis of postoperative venous thromboembolism using enoxaparin after esophagectomy: a prospective observational study of effectiveness and safety. Ann Surg Oncol. 2018;25:2434–40.CrossRefPubMed
6.
go back to reference Kato F, Takeuchi H, Matsuda S, Kawakubo H, Omori T, Kitagawa Y. Incidence of and risk factors for venous thromboembolism during surgical treatment for esophageal cancer: a single-institution study. Surg Today. 2016;46(4):445–52.CrossRefPubMed Kato F, Takeuchi H, Matsuda S, Kawakubo H, Omori T, Kitagawa Y. Incidence of and risk factors for venous thromboembolism during surgical treatment for esophageal cancer: a single-institution study. Surg Today. 2016;46(4):445–52.CrossRefPubMed
Metadata
Title
ASO Author Reflections: Venous Thromboembolism After Esophagectomy—The Importance of an Optimal Strategy for Thromboprophylaxis
Authors
Naoya Yoshida, MD, PhD
Hideo Baba, MD, PhD
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6883-x

Other articles of this Special Issue 3/2018

Annals of Surgical Oncology 3/2018 Go to the issue